175 related articles for article (PubMed ID: 3023829)
1. Viral transfer, transcription, and rescue of a selectable myeloproliferative sarcoma virus in embryonal cell lines: expression of the mos oncogene.
Seliger B; Kollek R; Stocking C; Franz T; Ostertag W
Mol Cell Biol; 1986 Jan; 6(1):286-93. PubMed ID: 3023829
[TBL] [Abstract][Full Text] [Related]
2. Retroviral mutants efficiently expressed in embryonal carcinoma cells.
Franz T; Hilberg F; Seliger B; Stocking C; Ostertag W
Proc Natl Acad Sci U S A; 1986 May; 83(10):3292-6. PubMed ID: 3010288
[TBL] [Abstract][Full Text] [Related]
3. The myeloproliferative sarcoma virus retains transforming functions after introduction of a dominant selectable marker gene.
Ostertag W; Seliger B; Kollek R; Stocking C; Bergholz U; Smadja-Joffe F
J Gen Virol; 1986 Jul; 67 ( Pt 7)():1361-71. PubMed ID: 3014049
[TBL] [Abstract][Full Text] [Related]
4. Stable expression of a selectable myeloproliferative sarcoma virus in murine T lymphocyte and monocyte cell lines.
Seliger B; Kruppa G; Pfizenmaier K
Immunobiology; 1987 May; 174(3):313-25. PubMed ID: 3040583
[TBL] [Abstract][Full Text] [Related]
5. Point mutations in the U3 region of the long terminal repeat of Moloney murine leukemia virus determine disease specificity of the myeloproliferative sarcoma virus.
Stocking C; Kollek R; Bergholz U; Ostertag W
Virology; 1986 Aug; 153(1):145-9. PubMed ID: 3016984
[TBL] [Abstract][Full Text] [Related]
6. Comparison of myeloproliferative sarcoma virus with Moloney murine sarcoma virus variants by nucleotide sequencing and heteroduplex analysis.
Stacey A; Arbuthnott C; Kollek R; Coggins L; Ostertag W
J Virol; 1984 Jun; 50(3):725-32. PubMed ID: 6328002
[TBL] [Abstract][Full Text] [Related]
7. A temperature-sensitive mutant of the myeloproliferative sarcoma virus, altered by a point mutation in the mos oncogene, has been modified as a selectable retroviral vector.
Friel J; Stocking C; Stacey A; Ostertag W
J Virol; 1987 Mar; 61(3):889-97. PubMed ID: 3027415
[TBL] [Abstract][Full Text] [Related]
8. Murine gamma interferon inhibits v-mos-induced fibroblast transformation via down regulation of retroviral gene expression.
Seliger B; Kruppa G; Pfizenmaier K
J Virol; 1987 Aug; 61(8):2567-72. PubMed ID: 3037117
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and characterization of a leukemia-inducing myeloproliferative sarcoma virus and two of its temperature-sensitive mutants.
Kollek R; Stocking C; Smadja-Joffe F; Ostertag W
J Virol; 1984 Jun; 50(3):717-24. PubMed ID: 6328001
[TBL] [Abstract][Full Text] [Related]
10. v-mos proteins encoded by myeloproliferative sarcoma virus and its ts159 mutant.
Singh B; Stocking C; Walker R; Yang YD; Ostertag W; Arlinghaus RB
J Virol; 1992 Feb; 66(2):1267-72. PubMed ID: 1309903
[TBL] [Abstract][Full Text] [Related]
11. Temperature-sensitive viral RNA expression in Moloney murine sarcoma virus ts110-infected cells.
Hamelin R; Brizzard BL; Nash MA; Murphy EC; Arlinghaus RB
J Virol; 1985 Feb; 53(2):616-23. PubMed ID: 2982039
[TBL] [Abstract][Full Text] [Related]
12. Study of the 78A1 isolate of Moloney murine sarcoma virus. I. Molecular cloning and characterization.
Devaux J; Jouanneau J; Quibriac M; Longuet M; Le Bousse-Kerdiles MC; Auger-Buendia MA; Tavitian A
J Gen Virol; 1985 Nov; 66 ( Pt 11)():2407-14. PubMed ID: 2997374
[TBL] [Abstract][Full Text] [Related]
13. Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon.
Sergiescu D; Gerfaux J; Joret AM; Chany C
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5764-8. PubMed ID: 3016718
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of the requirement for feeder cell interaction and T cell receptor stimulation of lymphocytes infected with retroviral vectors.
Laker C; Gräning G; Kelso A; Stocking C; Ostertag W
J Exp Med; 1990 Aug; 172(2):447-56. PubMed ID: 2165126
[TBL] [Abstract][Full Text] [Related]
15. Isolation of embryonal carcinoma cell lines that express integrated recombinant genes flanked by the Moloney murine leukemia virus long terminal repeat.
Taketo M; Gilboa E; Sherman MI
Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2422-6. PubMed ID: 3857593
[TBL] [Abstract][Full Text] [Related]
16. Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma virus.
Stocking C; Kollek R; Bergholz U; Ostertag W
Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5746-50. PubMed ID: 2994046
[TBL] [Abstract][Full Text] [Related]
17. Rates of evolution of the retroviral oncogene of Moloney murine sarcoma virus and of its cellular homologues.
Gojobori T; Yokoyama S
Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4198-201. PubMed ID: 2987967
[TBL] [Abstract][Full Text] [Related]
18. A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern.
Fusco A; Portella G; Di Fiore PP; Berlingieri MT; Di Lauro R; Schneider AB; Vecchio G
J Virol; 1985 Oct; 56(1):284-92. PubMed ID: 2993656
[TBL] [Abstract][Full Text] [Related]
19. Murine sarcoma virus ts110 RNA transcripts: origin from a single proviral DNA and sequence of the gag-mos junctions in both the precursor and spliced viral RNAs.
Nash MA; Brizzard BL; Wong JL; Murphy EC
J Virol; 1985 Feb; 53(2):624-33. PubMed ID: 2982040
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis underlying phenotypic revertants of Moloney murine sarcoma virus MuSVts110.
Cizdziel PE; Nash MA; Blair DG; Murphy EC
J Virol; 1986 Jan; 57(1):310-7. PubMed ID: 3001354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
